ImmunityBio, Inc. (IBRX) short interest & options flow
NASDAQIBRX utilization hits 92.42%, highest level since reaching 100% in the past year, as shares to borrow grow scarce for the heavily shorted biotech name.
- Market cap
- $7.18B
- Next earnings
- 12 Nov 2026
Key data as of 11 Nov 2026

Latest signals on IBRX
- Utilization
IBRX utilization hits 92.42%, highest level since reaching 100% in the past year, as shares to borrow grow scarce for the heavily shorted biotech name.
6 Utilization updates in 30 days
IBRX news and analysis
RSSNo long-form analysis yet for IBRX. Pulse alerts and the live data picture are available on ORTEX.
Open IBRX on ORTEX →Want the live picture for IBRX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IBRX — free to start on ORTEX.
Sign up for free →Open IBRX on ORTEX